Concepts (337)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colitis, Ulcerative | 15 | 2019 | 1922 | 0.780 |
Why?
|
| Diverticulosis, Colonic | 1 | 2016 | 9 | 0.540 |
Why?
|
| Dietary Fiber | 1 | 2016 | 759 | 0.400 |
Why?
|
| Gastrointestinal Agents | 6 | 2019 | 510 | 0.320 |
Why?
|
| Duodenal Ulcer | 1 | 2007 | 121 | 0.290 |
Why?
|
| Ampulla of Vater | 1 | 2007 | 149 | 0.280 |
Why?
|
| Crohn Disease | 11 | 2018 | 2279 | 0.280 |
Why?
|
| Mesalamine | 2 | 2009 | 135 | 0.230 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 4 | 2013 | 2273 | 0.220 |
Why?
|
| Cytomegalovirus Infections | 5 | 2019 | 831 | 0.220 |
Why?
|
| Esophagitis | 1 | 2005 | 164 | 0.220 |
Why?
|
| Proctocolectomy, Restorative | 3 | 2019 | 190 | 0.210 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2007 | 617 | 0.190 |
Why?
|
| Methotrexate | 4 | 2004 | 1719 | 0.180 |
Why?
|
| Eosinophilia | 1 | 2005 | 560 | 0.170 |
Why?
|
| Inflammatory Bowel Diseases | 3 | 2019 | 2422 | 0.170 |
Why?
|
| Isoxazoles | 1 | 2000 | 232 | 0.160 |
Why?
|
| Ileostomy | 1 | 2019 | 121 | 0.160 |
Why?
|
| Deglutition Disorders | 1 | 2005 | 625 | 0.160 |
Why?
|
| Biological Products | 2 | 2018 | 914 | 0.160 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2003 | 1809 | 0.140 |
Why?
|
| Immunosuppressive Agents | 2 | 2018 | 4176 | 0.130 |
Why?
|
| Colectomy | 2 | 2019 | 688 | 0.130 |
Why?
|
| Biological Therapy | 1 | 2017 | 141 | 0.130 |
Why?
|
| Insurance, Health | 2 | 2019 | 2499 | 0.130 |
Why?
|
| Dexamethasone | 1 | 2003 | 1948 | 0.130 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2014 | 874 | 0.120 |
Why?
|
| Diverticulitis, Colonic | 1 | 2016 | 138 | 0.120 |
Why?
|
| Gallstones | 3 | 1989 | 284 | 0.120 |
Why?
|
| Liver Cirrhosis | 4 | 2000 | 1935 | 0.120 |
Why?
|
| Geography | 1 | 2016 | 656 | 0.110 |
Why?
|
| Colonoscopy | 2 | 2019 | 1394 | 0.110 |
Why?
|
| Drug Monitoring | 1 | 2019 | 962 | 0.110 |
Why?
|
| Informed Consent | 1 | 2019 | 1008 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2019 | 4352 | 0.100 |
Why?
|
| Diabetes Complications | 3 | 1993 | 1315 | 0.100 |
Why?
|
| Histocytochemistry | 1 | 2013 | 698 | 0.100 |
Why?
|
| Hospital Costs | 1 | 2018 | 947 | 0.100 |
Why?
|
| Sex Distribution | 1 | 2016 | 2280 | 0.090 |
Why?
|
| Age Distribution | 1 | 2016 | 2879 | 0.090 |
Why?
|
| Gastrointestinal Diseases | 2 | 1993 | 1200 | 0.080 |
Why?
|
| Celiac Disease | 4 | 2011 | 821 | 0.080 |
Why?
|
| Patient Education as Topic | 1 | 2019 | 2319 | 0.080 |
Why?
|
| Diagnosis, Differential | 5 | 2016 | 12973 | 0.080 |
Why?
|
| Postoperative Complications | 5 | 2019 | 15633 | 0.080 |
Why?
|
| Immunologic Factors | 1 | 2018 | 1590 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 5 | 2010 | 9177 | 0.080 |
Why?
|
| Liver Diseases | 2 | 1997 | 1297 | 0.080 |
Why?
|
| Hydrothorax | 2 | 1997 | 18 | 0.070 |
Why?
|
| Endoscopy | 3 | 2016 | 1851 | 0.070 |
Why?
|
| Muramidase | 3 | 1976 | 169 | 0.070 |
Why?
|
| Hydrogen | 1 | 2007 | 172 | 0.070 |
Why?
|
| Middle Aged | 33 | 2019 | 220921 | 0.070 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2013 | 1844 | 0.060 |
Why?
|
| Serum Albumin, Bovine | 2 | 1977 | 321 | 0.060 |
Why?
|
| Prevalence | 3 | 2019 | 15733 | 0.060 |
Why?
|
| Adjuvants, Immunologic | 2 | 2004 | 1036 | 0.060 |
Why?
|
| Stomach Diseases | 2 | 1983 | 134 | 0.060 |
Why?
|
| Colon | 1 | 2013 | 1792 | 0.060 |
Why?
|
| Drug Therapy, Combination | 3 | 2018 | 6312 | 0.060 |
Why?
|
| Health Policy | 1 | 2017 | 2684 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 4016 | 0.060 |
Why?
|
| Educational Technology | 1 | 2005 | 59 | 0.060 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 2 | 1989 | 506 | 0.060 |
Why?
|
| Remission Induction | 3 | 2018 | 2397 | 0.060 |
Why?
|
| Humans | 62 | 2019 | 761596 | 0.060 |
Why?
|
| Metoclopramide | 1 | 1983 | 51 | 0.060 |
Why?
|
| Pulse Therapy, Drug | 1 | 2003 | 37 | 0.060 |
Why?
|
| Male | 35 | 2019 | 360846 | 0.060 |
Why?
|
| Carbon | 1 | 2007 | 666 | 0.050 |
Why?
|
| Inflammation | 2 | 2013 | 10774 | 0.050 |
Why?
|
| Adult | 25 | 2019 | 221210 | 0.050 |
Why?
|
| Fistula | 1 | 2004 | 212 | 0.050 |
Why?
|
| Paralysis | 1 | 1983 | 250 | 0.050 |
Why?
|
| Lymphoma, T-Cell | 1 | 2004 | 304 | 0.050 |
Why?
|
| Antibody Formation | 2 | 1977 | 1395 | 0.050 |
Why?
|
| Cholestasis | 2 | 1989 | 378 | 0.050 |
Why?
|
| Hospitalization | 2 | 2018 | 10721 | 0.050 |
Why?
|
| Varicose Veins | 1 | 1982 | 155 | 0.050 |
Why?
|
| Intestinal Absorption | 1 | 1982 | 400 | 0.050 |
Why?
|
| Siblings | 1 | 2005 | 825 | 0.040 |
Why?
|
| Hyalin | 1 | 1980 | 34 | 0.040 |
Why?
|
| Gastrointestinal Motility | 1 | 1982 | 234 | 0.040 |
Why?
|
| Ileum | 1 | 1982 | 557 | 0.040 |
Why?
|
| Bile Ducts, Intrahepatic | 2 | 1983 | 296 | 0.040 |
Why?
|
| Diabetic Neuropathies | 1 | 1983 | 405 | 0.040 |
Why?
|
| Female | 33 | 2019 | 392705 | 0.040 |
Why?
|
| Ileus | 1 | 2019 | 66 | 0.040 |
Why?
|
| Gastrointestinal Hemorrhage | 3 | 2004 | 1116 | 0.040 |
Why?
|
| Aged, 80 and over | 5 | 2019 | 58984 | 0.040 |
Why?
|
| Administration, Rectal | 1 | 1999 | 70 | 0.040 |
Why?
|
| Duodenum | 3 | 2011 | 490 | 0.040 |
Why?
|
| Choriocarcinoma | 1 | 1979 | 121 | 0.040 |
Why?
|
| Failure to Thrive | 1 | 2019 | 140 | 0.040 |
Why?
|
| Parenteral Nutrition, Total | 1 | 2019 | 304 | 0.040 |
Why?
|
| Clinical Clerkship | 1 | 2005 | 564 | 0.040 |
Why?
|
| Aged | 18 | 2019 | 169310 | 0.040 |
Why?
|
| Biliary Tract Diseases | 1 | 1979 | 159 | 0.040 |
Why?
|
| Liver | 5 | 2000 | 7528 | 0.040 |
Why?
|
| Medication Adherence | 1 | 2009 | 2176 | 0.040 |
Why?
|
| Internal Medicine | 1 | 2005 | 1051 | 0.040 |
Why?
|
| Administration, Oral | 3 | 1999 | 4021 | 0.040 |
Why?
|
| Hyperthyroidism | 1 | 1979 | 294 | 0.040 |
Why?
|
| Adenoma, Bile Duct | 1 | 1976 | 29 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2007 | 3769 | 0.030 |
Why?
|
| Tetracycline | 1 | 1977 | 216 | 0.030 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 1 | 1997 | 95 | 0.030 |
Why?
|
| Cytomegalovirus | 2 | 2019 | 756 | 0.030 |
Why?
|
| Severity of Illness Index | 5 | 2013 | 15843 | 0.030 |
Why?
|
| Dysgammaglobulinemia | 1 | 1975 | 19 | 0.030 |
Why?
|
| Intestinal Obstruction | 1 | 2019 | 432 | 0.030 |
Why?
|
| Cholangitis | 1 | 1976 | 111 | 0.030 |
Why?
|
| Immunoglobulin A | 2 | 1976 | 978 | 0.030 |
Why?
|
| Length of Stay | 2 | 2019 | 6426 | 0.030 |
Why?
|
| Hydrocortisone | 1 | 2003 | 1819 | 0.030 |
Why?
|
| Gastritis | 3 | 2004 | 199 | 0.030 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2000 | 3763 | 0.030 |
Why?
|
| Cholelithiasis | 1 | 1976 | 407 | 0.030 |
Why?
|
| Anastomosis, Surgical | 1 | 2018 | 983 | 0.030 |
Why?
|
| Diatrizoate | 1 | 1974 | 81 | 0.030 |
Why?
|
| Melena | 1 | 1974 | 32 | 0.030 |
Why?
|
| Vitamin A | 1 | 1977 | 613 | 0.030 |
Why?
|
| Pleural Effusion | 1 | 1977 | 341 | 0.030 |
Why?
|
| Fatty Liver | 1 | 1980 | 790 | 0.030 |
Why?
|
| Abdomen, Acute | 1 | 1974 | 122 | 0.030 |
Why?
|
| Risk Factors | 3 | 2016 | 74213 | 0.030 |
Why?
|
| Time Factors | 4 | 2019 | 39969 | 0.030 |
Why?
|
| Education, Medical, Graduate | 1 | 2005 | 2373 | 0.030 |
Why?
|
| Vasopressins | 1 | 1973 | 351 | 0.030 |
Why?
|
| Nitrosamines | 2 | 1982 | 87 | 0.020 |
Why?
|
| Serum | 1 | 2013 | 209 | 0.020 |
Why?
|
| Antigens | 1 | 1977 | 1443 | 0.020 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 1975 | 547 | 0.020 |
Why?
|
| Curriculum | 1 | 2005 | 3743 | 0.020 |
Why?
|
| C-Reactive Protein | 2 | 2013 | 3826 | 0.020 |
Why?
|
| Prednisone | 3 | 2004 | 1563 | 0.020 |
Why?
|
| Bile Duct Neoplasms | 1 | 1976 | 605 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2013 | 39106 | 0.020 |
Why?
|
| Uterine Neoplasms | 1 | 1979 | 1420 | 0.020 |
Why?
|
| Methods | 2 | 1983 | 1067 | 0.020 |
Why?
|
| Surgical Wound Infection | 1 | 2019 | 1529 | 0.020 |
Why?
|
| Venous Thrombosis | 1 | 2019 | 1303 | 0.020 |
Why?
|
| Prospective Studies | 6 | 2016 | 54423 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2019 | 2220 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 1999 | 12341 | 0.020 |
Why?
|
| United States | 4 | 2019 | 72340 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2018 | 6345 | 0.020 |
Why?
|
| Mortality | 1 | 2019 | 2902 | 0.020 |
Why?
|
| Maximum Tolerated Dose | 1 | 2010 | 883 | 0.020 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1973 | 732 | 0.020 |
Why?
|
| Laparoscopy | 1 | 2019 | 2036 | 0.020 |
Why?
|
| Insurance Coverage | 1 | 2019 | 1940 | 0.020 |
Why?
|
| Liver Regeneration | 1 | 1989 | 213 | 0.020 |
Why?
|
| Methyl Ethers | 1 | 1989 | 196 | 0.020 |
Why?
|
| Smoking | 1 | 2004 | 9053 | 0.020 |
Why?
|
| Biopsy | 3 | 2013 | 6766 | 0.020 |
Why?
|
| Hemorrhage | 1 | 1979 | 3424 | 0.020 |
Why?
|
| Cohort Studies | 3 | 2019 | 41495 | 0.020 |
Why?
|
| Recurrence | 2 | 2016 | 8466 | 0.020 |
Why?
|
| Cell Extracts | 1 | 2007 | 135 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1999 | 10766 | 0.020 |
Why?
|
| Survival Rate | 2 | 2011 | 12723 | 0.020 |
Why?
|
| Entropy | 1 | 2007 | 210 | 0.020 |
Why?
|
| Carbon Isotopes | 1 | 2007 | 458 | 0.020 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 1986 | 2199 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2011 | 1869 | 0.020 |
Why?
|
| Fourier Analysis | 1 | 2007 | 441 | 0.020 |
Why?
|
| Safety | 1 | 2010 | 1149 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2011 | 1626 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2010 | 2217 | 0.020 |
Why?
|
| Foreign Bodies | 1 | 1969 | 402 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2019 | 3271 | 0.020 |
Why?
|
| Pregnancy Complications | 1 | 1979 | 2947 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2007 | 20568 | 0.020 |
Why?
|
| Granulocytes | 1 | 2007 | 551 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 2004 | 5821 | 0.020 |
Why?
|
| Prognosis | 3 | 2013 | 29629 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3779 | 0.010 |
Why?
|
| Treatment Outcome | 5 | 2010 | 64685 | 0.010 |
Why?
|
| Europe | 1 | 2011 | 3420 | 0.010 |
Why?
|
| Pacemaker, Artificial | 1 | 1969 | 807 | 0.010 |
Why?
|
| Lymphoma | 2 | 1986 | 1901 | 0.010 |
Why?
|
| Retrospective Studies | 3 | 2019 | 80647 | 0.010 |
Why?
|
| Random Allocation | 2 | 1988 | 2395 | 0.010 |
Why?
|
| Cranial Nerve Diseases | 1 | 1983 | 113 | 0.010 |
Why?
|
| Mutagenicity Tests | 1 | 1982 | 46 | 0.010 |
Why?
|
| Age Factors | 1 | 2019 | 18399 | 0.010 |
Why?
|
| Patient Simulation | 1 | 2005 | 298 | 0.010 |
Why?
|
| Carcinoma | 1 | 1973 | 2330 | 0.010 |
Why?
|
| Vincristine | 1 | 2004 | 1036 | 0.010 |
Why?
|
| Gastric Juice | 1 | 1981 | 59 | 0.010 |
Why?
|
| Gastritis, Atrophic | 1 | 1981 | 31 | 0.010 |
Why?
|
| Coccidiosis | 1 | 1981 | 10 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 7391 | 0.010 |
Why?
|
| Tissue Adhesions | 1 | 1982 | 218 | 0.010 |
Why?
|
| Nitrites | 1 | 1981 | 159 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 1980 | 5841 | 0.010 |
Why?
|
| Intestinal Diseases, Parasitic | 1 | 1981 | 64 | 0.010 |
Why?
|
| Esophageal Diseases | 1 | 1982 | 168 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 10212 | 0.010 |
Why?
|
| Duodenal Diseases | 1 | 1981 | 100 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2003 | 1379 | 0.010 |
Why?
|
| Vagus Nerve | 1 | 1983 | 458 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 1976 | 4317 | 0.010 |
Why?
|
| Hepatomegaly | 1 | 1980 | 84 | 0.010 |
Why?
|
| Common Bile Duct Neoplasms | 1 | 1980 | 120 | 0.010 |
Why?
|
| Salmonella typhimurium | 1 | 1982 | 347 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2004 | 1835 | 0.010 |
Why?
|
| Social Support | 1 | 2009 | 2172 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 15266 | 0.010 |
Why?
|
| Cholangiography | 2 | 1977 | 181 | 0.010 |
Why?
|
| Azathioprine | 1 | 2000 | 354 | 0.010 |
Why?
|
| Blood Sedimentation | 1 | 1980 | 235 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 2004 | 2220 | 0.010 |
Why?
|
| Esophageal and Gastric Varices | 1 | 1980 | 208 | 0.010 |
Why?
|
| Liver Function Tests | 1 | 1980 | 523 | 0.010 |
Why?
|
| Diarrhea | 2 | 1982 | 1318 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 1983 | 1702 | 0.010 |
Why?
|
| Bile | 1 | 1979 | 298 | 0.010 |
Why?
|
| Constipation | 1 | 1982 | 563 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 1977 | 413 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 9420 | 0.010 |
Why?
|
| Lymphocytes | 2 | 1982 | 2612 | 0.010 |
Why?
|
| Blood | 1 | 1979 | 596 | 0.010 |
Why?
|
| Neoplasm Metastasis | 2 | 1979 | 4915 | 0.010 |
Why?
|
| Immunoelectrophoresis | 1 | 1975 | 94 | 0.010 |
Why?
|
| Hepatitis | 1 | 1978 | 228 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 1977 | 681 | 0.010 |
Why?
|
| Young Adult | 2 | 2014 | 59260 | 0.010 |
Why?
|
| Pleura | 1 | 1977 | 245 | 0.010 |
Why?
|
| Colitis | 1 | 1983 | 1233 | 0.010 |
Why?
|
| Clinical Enzyme Tests | 1 | 1975 | 113 | 0.010 |
Why?
|
| Ascites | 1 | 1977 | 338 | 0.010 |
Why?
|
| Barium Sulfate | 1 | 1975 | 180 | 0.010 |
Why?
|
| Sigmoidoscopy | 1 | 1975 | 151 | 0.010 |
Why?
|
| Enema | 1 | 1975 | 141 | 0.010 |
Why?
|
| Antibodies | 1 | 2003 | 2418 | 0.010 |
Why?
|
| Pancreatic Diseases | 1 | 1977 | 343 | 0.010 |
Why?
|
| Glucuronidase | 1 | 1976 | 202 | 0.010 |
Why?
|
| Histocompatibility Antigens | 1 | 1975 | 464 | 0.010 |
Why?
|
| Pyelonephritis | 1 | 1974 | 75 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1997 | 672 | 0.010 |
Why?
|
| Respiration Disorders | 1 | 1997 | 367 | 0.010 |
Why?
|
| Radiography | 3 | 1992 | 6965 | 0.010 |
Why?
|
| Enteritis | 1 | 1975 | 162 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 2007 | 18966 | 0.010 |
Why?
|
| Mesenteric Arteries | 1 | 1974 | 178 | 0.010 |
Why?
|
| Salmonella Infections | 1 | 1975 | 172 | 0.010 |
Why?
|
| Histocompatibility Testing | 1 | 1975 | 712 | 0.010 |
Why?
|
| Granuloma | 1 | 1976 | 328 | 0.010 |
Why?
|
| Angiography | 1 | 1979 | 1595 | 0.010 |
Why?
|
| Jejunum | 1 | 1975 | 472 | 0.010 |
Why?
|
| Animals | 5 | 2007 | 168475 | 0.010 |
Why?
|
| Glutens | 1 | 1975 | 240 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1973 | 659 | 0.010 |
Why?
|
| Incidence | 1 | 2011 | 21355 | 0.010 |
Why?
|
| HLA Antigens | 1 | 1978 | 1328 | 0.010 |
Why?
|
| Homosexuality | 2 | 1983 | 267 | 0.010 |
Why?
|
| Boston | 1 | 2005 | 9327 | 0.010 |
Why?
|
| Clinical Trials as Topic | 2 | 1988 | 8002 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2004 | 2781 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2005 | 8633 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2003 | 8527 | 0.010 |
Why?
|
| Hyponatremia | 1 | 1973 | 279 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 1975 | 1596 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 1976 | 1526 | 0.010 |
Why?
|
| Gene Frequency | 1 | 1978 | 3606 | 0.010 |
Why?
|
| Dietary Proteins | 1 | 1976 | 952 | 0.010 |
Why?
|
| Cattle | 1 | 1976 | 3849 | 0.010 |
Why?
|
| Esophageal Neoplasms | 1 | 1979 | 1654 | 0.010 |
Why?
|
| Glycerides | 1 | 1989 | 67 | 0.010 |
Why?
|
| Adolescent | 2 | 2014 | 88326 | 0.010 |
Why?
|
| Ethers | 1 | 1989 | 73 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2005 | 4793 | 0.010 |
Why?
|
| Caprylates | 1 | 1989 | 115 | 0.000 |
Why?
|
| Sodium | 1 | 1973 | 1588 | 0.000 |
Why?
|
| Quality of Life | 1 | 2009 | 13367 | 0.000 |
Why?
|
| Pulmonary Fibrosis | 1 | 1992 | 505 | 0.000 |
Why?
|
| Tablets | 1 | 1988 | 148 | 0.000 |
Why?
|
| Disease Progression | 1 | 2004 | 13510 | 0.000 |
Why?
|
| Syndrome | 1 | 1973 | 3267 | 0.000 |
Why?
|
| Mice | 3 | 2007 | 81539 | 0.000 |
Why?
|
| Acute Kidney Injury | 1 | 1979 | 1924 | 0.000 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1975 | 1881 | 0.000 |
Why?
|
| Intestinal Mucosa | 1 | 1977 | 3032 | 0.000 |
Why?
|
| Deltaretrovirus | 1 | 1986 | 162 | 0.000 |
Why?
|
| Monocytes | 1 | 1975 | 2570 | 0.000 |
Why?
|
| Liver Transplantation | 1 | 1997 | 2330 | 0.000 |
Why?
|
| Chronic Disease | 2 | 1978 | 9319 | 0.000 |
Why?
|
| Renal Dialysis | 1 | 1974 | 1796 | 0.000 |
Why?
|
| Drug Administration Schedule | 1 | 1992 | 4853 | 0.000 |
Why?
|
| Immunoglobulin G | 1 | 1976 | 4544 | 0.000 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2004 | 11742 | 0.000 |
Why?
|
| Catheterization | 1 | 1989 | 1428 | 0.000 |
Why?
|
| Adenocarcinoma | 1 | 1980 | 6345 | 0.000 |
Why?
|
| Immunoglobulins | 1 | 1986 | 852 | 0.000 |
Why?
|
| Diploidy | 1 | 1982 | 132 | 0.000 |
Why?
|
| Thiocyanates | 1 | 1981 | 70 | 0.000 |
Why?
|
| Kidney Failure, Chronic | 1 | 1974 | 2472 | 0.000 |
Why?
|
| Recombination, Genetic | 1 | 1986 | 1519 | 0.000 |
Why?
|
| Splenorenal Shunt, Surgical | 1 | 1980 | 14 | 0.000 |
Why?
|
| Venae Cavae | 1 | 1980 | 40 | 0.000 |
Why?
|
| Portasystemic Shunt, Surgical | 1 | 1980 | 39 | 0.000 |
Why?
|
| Colombia | 1 | 1981 | 282 | 0.000 |
Why?
|
| Duodenitis | 1 | 1980 | 20 | 0.000 |
Why?
|
| Nitrates | 1 | 1981 | 263 | 0.000 |
Why?
|
| Herpesvirus 4, Human | 1 | 1986 | 1078 | 0.000 |
Why?
|
| Oncogenes | 1 | 1986 | 1222 | 0.000 |
Why?
|
| Macrophages | 1 | 1975 | 5767 | 0.000 |
Why?
|
| Esophagoscopy | 1 | 1980 | 396 | 0.000 |
Why?
|
| T-Lymphocytes | 2 | 1988 | 10194 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1981 | 2561 | 0.000 |
Why?
|
| Urography | 1 | 1979 | 316 | 0.000 |
Why?
|
| Obesity | 1 | 1980 | 12947 | 0.000 |
Why?
|
| Pregnancy | 1 | 1979 | 29890 | 0.000 |
Why?
|
| Pain | 1 | 1992 | 5073 | 0.000 |
Why?
|
| Iodine | 1 | 1979 | 288 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 1979 | 13642 | 0.000 |
Why?
|
| Ultrasonography | 1 | 1989 | 5971 | 0.000 |
Why?
|
| Schistosomiasis | 1 | 1976 | 65 | 0.000 |
Why?
|
| Protein-Losing Enteropathies | 1 | 1975 | 45 | 0.000 |
Why?
|
| Schistosoma mansoni | 1 | 1976 | 155 | 0.000 |
Why?
|
| Antibodies, Viral | 1 | 1986 | 3156 | 0.000 |
Why?
|
| Hypertrophy | 1 | 1975 | 561 | 0.000 |
Why?
|
| B-Lymphocytes | 1 | 1986 | 4758 | 0.000 |
Why?
|
| Intestines | 1 | 1981 | 1910 | 0.000 |
Why?
|
| Cell Survival | 1 | 1982 | 5791 | 0.000 |
Why?
|
| Child | 2 | 1981 | 80158 | 0.000 |
Why?
|
| Epitopes | 1 | 1978 | 2503 | 0.000 |
Why?
|
| Stomach | 1 | 1975 | 696 | 0.000 |
Why?
|
| Risk | 1 | 1981 | 9610 | 0.000 |
Why?
|
| Massachusetts | 1 | 1981 | 8833 | 0.000 |
Why?
|
| Cell Line | 1 | 1982 | 15601 | 0.000 |
Why?
|
| Contrast Media | 1 | 1979 | 5307 | 0.000 |
Why?
|
| Lung | 1 | 1983 | 10002 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1981 | 42232 | 0.000 |
Why?
|
| Mutation | 1 | 1982 | 30053 | 0.000 |
Why?
|
Concepts
(337)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(42)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_